Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma

被引:13
|
作者
Mundada, Pravin [1 ]
Varoquaux, Arthur Damien [2 ]
Lenoir, Vincent [1 ]
de Vito, Claudio [3 ]
Dulguerov, Nicolas [4 ]
Ailianou, Angeliki [1 ,6 ]
Caparrotti, Francesca [5 ]
Becker, Minerva [1 ]
机构
[1] Univ Geneva, Geneva Univ Hosp, Div Radiol, Dept Imaging & Med Informat, Geneva, Switzerland
[2] Aix Marseille Med Univ, Ctr Magnet Resonance Biol & Med, Marseille, France
[3] Univ Geneva, Geneva Univ Hosp, Dept Lab Med Genet & Pathol, Div Clin Pathol, Geneva, Switzerland
[4] Univ Geneva, Geneva Univ Hosp, Dept Clin Neurosci, Clin Otorhinolaryngol Head & Neck Surg, Geneva, Switzerland
[5] Geneva Univ Hosp, Dept Oncol, Div Radiat Oncol, Geneva, Switzerland
[6] Hosp Neuchatel, Dept Imaging, Div Radiol, Neuchatel, Switzerland
关键词
Head and neck squamous cell carcinoma; Post-treatment loco-regional failure; Lymph node recurrence; Diffusion weighted imaging; MRI; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; RADIATION TREATMENT; FOLLOW-UP; CHEMORADIOTHERAPY; CANCER; TUMORS; RADIOTHERAPY; METAANALYSIS; METASTASIS;
D O I
10.1016/j.ejrad.2018.02.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine the diagnostic performance of morphologic MRI with diffusion weighted imaging (DWIMRI) for the detection of post-treatment lymph node (LN) recurrence of head and neck squamous cell carcinoma (HNSCC). Methods: This retrospective study is based on 33 HNSCC patients who underwent DWIMRI with apparent diffusion coefficient (ADC) measurements for suspected post-treatment loco-regional failure. Two radiologists, blinded to clinical/histopathological data, analyzed MR images according to established morphologic criteria and measured ADC values by drawing regions of interest on each normal/abnormal looking lymph node (LN). Histopathological findings in 40 neck dissections, 133 LN-levels and 755 LNs served as gold standard. Results: Malignant LNs had lower ADCmean values than benign LNs (1.15 +/- 0.35x10(-3) mm(2)/s versus 1.28 +/- 0.28x10(-3) mm(2)/s, p = .028). The optimal ADCmean threshold to differentiate malignant from benign LNs was 1.1695x10(-3) mm(2)/s. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values (95% CI in parentheses) of DWIMRI with morphologic criteria and ADCmean<1.1695x10(-3)mm(2)/s were: (a) 100%(86.2; 100), 44.4%(15.3; 77.3), 86.1%(69.7; 94.7), and 100%(39.5; 100) per neck dissection; (b) 83.6%(69.7; 92.2), 91.6%(83.0; 96.2), 85.4%(71.6; 93.4), and 90.5%(81.7; 95.5) per LN-level; (c) 53.1%(43.5; 62.4), 95.5%(93.5; 96.9), 67.4%(56.6; 76.7), and 92.0%(89.6; 93.9) per LN, respectively. Conclusion: The high NPV of DWIMRI irrespective of analysis type (per neck dissection/per neck level/per lymph node) make it a useful follow-up tool after treatment.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [1] Head and Neck Squamous Cell Carcinoma: Value of Diffusion-weighted MR Imaging for Nodal Staging
    Vandecaveye, Vincent
    De Keyzer, Frederik
    Vander Poorten, Vincent
    Dirix, Piet
    Verbeken, Eric
    Nuyts, Sandra
    Hermans, Robert
    RADIOLOGY, 2009, 251 (01) : 134 - 146
  • [2] DIFFUSION-WEIGHTED MRI FOR NODAL STAGING OF HEAD AND NECK SQUAMOUS CELL CARCINOMA: IMPACT ON RADIOTHERAPY PLANNING
    Dirix, Piet
    Vandecaveye, Vincent
    De Keyzer, Frederik
    De Beeck, Katya Op
    Vander Poorten, Vincent
    Delaere, Pierre
    Verbeken, Eric
    Hermans, Robert
    Nuyts, Sandra
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 761 - 766
  • [3] ACCURACY OF DIFFUSION-WEIGHTED MRI FOR NODAL STAGING AND RADIOTHERAPY PLANNING OF HEAD AND NECK SQUAMOUS CELL CARCINOMA.
    Vandecaveye, V.
    Dirix, P.
    De Keyzer, F.
    Op de Beeck, K.
    Poorten, V. Vander
    Delaere, P.
    Verbeken, E.
    Hermans, R.
    Nuyts, S.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S152 - S153
  • [4] Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy
    Brenet, Esteban
    Barbe, Coralie
    Hoeffel, Christine
    Dubernard, Xavier
    Merol, Jean-Claude
    Fath, Lea
    Servagi-Vernat, Stephanie
    Labrousse, Marc
    CANCERS, 2020, 12 (05)
  • [5] Residual tumour detection in post-treatment granulation tissue by using advanced diffusion models in head and neck squamous cell carcinoma patients
    Fujima, Noriyuki
    Yoshida, Daisuke
    Sakashita, Tomohiro
    Homma, Akihiro
    Kudo, Kohsuke
    Shirato, Hiroki
    EUROPEAN JOURNAL OF RADIOLOGY, 2017, 90 : 14 - 19
  • [6] Squamous Cell Carcinoma: PET/CT and PET/MRI of the Pretreatment and Post-Treatment Neck
    Traylor, Katie S.
    Koontz, Nicholas
    Mosier, Kristine
    SEMINARS IN ULTRASOUND CT AND MRI, 2019, 40 (05) : 400 - 413
  • [7] Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response
    Ann D. King
    Frankie K. F. Mo
    Kwok-Hung Yu
    David K. W. Yeung
    Hua Zhou
    Kunwar S. Bhatia
    Gary M. K. Tse
    Alexander C. Vlantis
    Jeffrey K. T. Wong
    Anil T. Ahuja
    European Radiology, 2010, 20 : 2213 - 2220
  • [8] Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response
    King, Ann D.
    Mo, Frankie K. F.
    Yu, Kwok-Hung
    Yeung, David K. W.
    Zhou, Hua
    Bhatia, Kunwar S.
    Tse, Gary M. K.
    Vlantis, Alexander C.
    Wong, Jeffrey K. T.
    Ahuja, Anil T.
    EUROPEAN RADIOLOGY, 2010, 20 (09) : 2213 - 2220
  • [9] MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter
    Ailianou, A.
    Mundada, P.
    De Perrot, T.
    Pusztaszieri, M.
    Poletti, P. -A.
    Becker, M.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (04) : 748 - 755
  • [10] Post-treatment FDG-PET CT in detecting residual disease in head & neck squamous cell carcinoma
    Price, J.
    Pascoe, A.
    Weston, C.
    Kathirgamakarthigeyan, S.
    Griffin, M.
    Ganatra, R.
    Christian, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S513 - S513